<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37887751</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Serological Biomarkers at Hospital Admission and Hospitalization Treatments Are Not Related to Sensitization-Associated Symptoms in Patients with Post-COVID Pain.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1235</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens12101235</ELocationID><Abstract><AbstractText>Current evidence suggests that a group of patients who had survived coronavirus disease, 2019 (COVID-19) and developed post-COVID pain can exhibit altered nociceptive processing. The role of serological biomarkers and hospitalization treatments in post-COVID pain is unclear. This study aimed to investigate the association of serological biomarkers and treatments received during hospitalization with sensitization-associated symptoms in COVID-19 survivors with post-COVID pain. One hundred and eighty-three (n = 183) patients who had been hospitalized due to COVID-19 in one urban hospital of Madrid (Spain) during the first wave of the pandemic were assessed in a face-to-face interview 9.4 (SD 3.4) months after hospitalization. Levels of 19 serological biomarkers, hospitalization data, and treatments during hospitalization were obtained from hospital records. Sensitization-associated symptoms (Central Sensitization Inventory, CSI), sleep quality (Pittsburgh Sleep Quality Index, PSQI), pain catastrophism (Pain Catastrophizing Scale), and anxiety/depressive level (Hospital Anxiety and Depression Scale, HADS) were assessed. The prevalence of post-COVID pain was 40.9% (n = 75). Twenty-nine (38.6%) patients had sensitization-associated symptoms. Overall, no differences in hospitalization data and serological biomarkers were identified according to the presence of sensitization-associated symptoms. The analysis revealed that patients with sensitization-associated symptoms exhibited higher lymphocyte count and lower urea levels than those without sensitization-associated symptoms, but differences were small. Pain catastrophism and depressive levels, but not fatigue, dyspnea, brain fog, anxiety levels, or poor sleep, were higher in individuals with sensitization-associated symptoms. In conclusion, this study revealed that sensitization-associated post-COVID pain symptoms are not associated with serological biomarkers at hospital admission and hospitalization treatments received.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guijarro</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8132-9366</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine-Infectious Department, Research Department, Hospital Universitario Fundaci&#xf3;n Alcorc&#xf3;n, 28922 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Macho</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>Oscar J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Image Processing Laboratory (IPL), Universitat de Val&#xe8;ncia, Parc Cient&#xed;fic, 46980 Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco-Moreno</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijs</LastName><ForeName>Jo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4976-6563</Identifier><AffiliationInfo><Affiliation>Pain in Motion Research Group (PAIN), Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education &amp; Physiotherapy, Vrije Universiteit Brussel, 1050 Ixelles, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chronic Pain Rehabilitation Center, Department of Physical Medicine and Physiotherapy, University Hospital Brussels, 1050 Ixelles, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Rehabilitation, Unit of Physiotherapy, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 41390 G&#xf6;terbog, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco-Arribas</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6554-2095</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine-Infectious Department, Research Department, Hospital Universitario Fundaci&#xf3;n Alcorc&#xf3;n, 28922 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LONG-COVID-EXP-CM</GrantID><Agency>Consejer&#xed;a de Econom&#xed;a, Empleo y Competitividad Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>NNF21OC0067235</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">sensitization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37887751</ArticleId><ArticleId IdType="pmc">PMC10610051</ArticleId><ArticleId IdType="doi">10.3390/pathogens12101235</ArticleId><ArticleId IdType="pii">pathogens12101235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A scoping review. Front. Med. 2021;8:750378. doi: 10.3389/fmed.2021.750378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Udeh R., Yon D.K., Lee S.W., Dolja-Gore X., McEVoy M., Kenna T., Jacob L., L&#xf3;pez S&#xe1;nchez G.F., Koyanagi A., et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J. Med. Virol. 2023;95:e28852. doi: 10.1002/jmv.28852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28852</ArticleId><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a Arendt-Nielsen L. Time course prevalence of Post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerzhner O., Berla E., Har-Even M., Ratmansky M., Goor-Aryeh I. Consistency of inconsistency in long-COVID-19 pain symptoms persistency: A systematic review and meta-analysis. Pain Pract. 2023. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.13277</ArticleId><ArticleId IdType="pubmed">37475709</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares F.H.C., Kubota G.T., Fernandes A.M., Hojo B., Couras C., Costa B.V., Lapa J.D.D.S., Braga L.M., Almeida M.M., Cunha P.H.M.D., et al. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur. J. Pain. 2021;25:1342&#x2013;1354. doi: 10.1002/ejp.1755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-Ljungar I., Norrefalk J.R., Borg K. Pain burden in post-COVID-19 syndrome following mild COVID-19 infection. J. Clin. Med. 2022;11:771. doi: 10.3390/jcm11030771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zis P., Ioannou C., Artemiadis A., Christodoulo K., Kalampokini S., Hadjigeorgiou G.M. Prevalence and determinants of chronic pain Post-COVID; cross-sectional study. J. Clin. Med. 2022;11:5569. doi: 10.3390/jcm11195569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195569</ArticleId><ArticleId IdType="pmc">PMC9573502</ArticleId><ArticleId IdType="pubmed">36233443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota G.T., Soares F.H.C., da Fonseca A.S., Rosa T.D.S., da Silva V.A., Gouveia G.R., Faria V.G., da Cunha P.H.M., Brunoni A.R., Teixeira M.J., et al. Pain paths among post-COVID-19 condition subjects: A prospective cross-sectional study with in-person evaluation. Eur. J. Pain. 2023;27:636&#x2013;650. doi: 10.1002/ejp.2094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.2094</ArticleId><ArticleId IdType="pubmed">36799447</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., de-la-Llave-Rinc&#xf3;n A.I., Ortega-Santiago R., Ambite-Quesada S., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Hern&#xe1;ndez-Barrera V., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: A multicenter study. Pain. 2022;163:e989&#x2013;e996. doi: 10.1097/j.pain.0000000000002564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., George S.Z., Clauw D.J., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Kosek E., Ickmans K., Fern&#xe1;ndez-Carnero J., Polli A., Kapreli E., Huysmans E., et al. Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3:e383&#x2013;e392. doi: 10.1016/S2665-9913(21)00032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00032-1</ArticleId><ArticleId IdType="pubmed">38279393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosek E., Clauw D., Nijs J., Baron R., Gilron I., Harris R.E., Mico J.A., Rice A.S.C., Sterling M. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain. 2021;162:2629&#x2013;2634. doi: 10.1097/j.pain.0000000000002324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002324</ArticleId><ArticleId IdType="pubmed">33974577</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzcharles M.A., Cohen S.P., Clauw D.J., Littlejohn G., Usui C., H&#xe4;user W. Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet. 2021;397:2098&#x2013;2110. doi: 10.1016/S0140-6736(21)00392-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00392-5</ArticleId><ArticleId IdType="pubmed">34062144</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Par&#xe1;s-Bravo P., Ferrer-Pargada D., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., Nijs J., Arendt-Nielsen L., Herrero-Montes M. Sensitization symptoms are associated with psychological and cognitive variables in COVID-19 survivors exhibiting post-COVID pain. Pain Pract. 2023;23:23&#x2013;31. doi: 10.1111/papr.13146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.13146</ArticleId><ArticleId IdType="pmc">PMC9350126</ArticleId><ArticleId IdType="pubmed">35757896</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudman L., De Smedt A., Noppen M., Moens M. Is central sensitisation the missing link of persisting symptoms after COVID-19 infection? J. Clin. Med. 2021;10:5594. doi: 10.3390/jcm10235594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235594</ArticleId><ArticleId IdType="pmc">PMC8658135</ArticleId><ArticleId IdType="pubmed">34884296</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudman L., De Smedt A., Roggeman S., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Hatem S.M., Schiltz M., Billot M., Roulaud M., Rigoard P., Moens M. Association between experimental pain measurements and the central sensitization inventory in patients at least 3 months after COVID-19 infection: A cross-sectional pilot study. J. Clin. Med. 2023;12:661. doi: 10.3390/jcm12020661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020661</ArticleId><ArticleId IdType="pmc">PMC9862134</ArticleId><ArticleId IdType="pubmed">36675590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethea J.R., Fischer R. Role of peripheral immune cells for development and recovery of chronic pain. Front. Immunol. 2021;12:641588. doi: 10.3389/fimmu.2021.641588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.641588</ArticleId><ArticleId IdType="pmc">PMC7937804</ArticleId><ArticleId IdType="pubmed">33692810</ArticleId></ArticleIdList></Reference><Reference><Citation>Samprathi M., Jayashree M. Biomarkers in COVID-19: An up-to-date review. Front. Pediatr. 2021;8:607647. doi: 10.3389/fped.2020.607647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.607647</ArticleId><ArticleId IdType="pmc">PMC8042162</ArticleId><ArticleId IdType="pubmed">33859967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T.I., Japar K.V., Kwenandar F., Damay V., Siregar J.I., Lugito N.P.H., Tjiang M.M., Kurniawan A. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis. Am. J. Emerg. Med. 2021;41:110&#x2013;119. doi: 10.1016/j.ajem.2020.12.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.12.076</ArticleId><ArticleId IdType="pmc">PMC7831442</ArticleId><ArticleId IdType="pubmed">33418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: A scoping review. eBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Liu S., Aljeldah M., Al Shammari B.R., Alwarthan S., Alhajri M., Alawfi A., Alshengeti A., et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers. Rev. Med. Virol. 2023;33:e2424. doi: 10.1002/rmv.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak&#x131;lan F., G&#xf6;kmen &#x130;.G., Ortanca B., U&#xe7;an A., Eker G&#xfc;ven&#xe7; &#x15e;., &#x15e;ahin Mutlu F., G&#xf6;kmen H.M., Ekim A. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int. J. Clin. Pract. 2021;75:e14734. doi: 10.1111/ijcp.14734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14734</ArticleId><ArticleId IdType="pmc">PMC8420386</ArticleId><ArticleId IdType="pubmed">34387911</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Ryan-Murua P., de-la-Llave-Rinc&#xf3;n A.I., G&#xf3;mez-Mayordomo V., Arendt-Nielsen L., Torres-Macho J. Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors. Pain. 2022;163:2112&#x2013;2117. doi: 10.1097/j.pain.0000000000002608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002608</ArticleId><ArticleId IdType="pmc">PMC9560903</ArticleId><ArticleId IdType="pubmed">35121694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Herrero-Montes M., Ferrer-Pargada D., Izquierdo-Cuervo S., Arendt-Nielsen L., Nijs J., Par&#xe1;s-Bravo P. Sensitization-associated post-COVID-19 symptoms at 6 months are not associated with serological biomarkers at hospital admission in COVID-19 survivors: A secondary analysis of a cohort study. J. Clin. Med. 2022;11:3512. doi: 10.3390/jcm11123512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123512</ArticleId><ArticleId IdType="pmc">PMC9225549</ArticleId><ArticleId IdType="pubmed">35743582</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D.J., H&#xe4;user W., Cohen S.P., Fitzcharles M.A. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161:1694&#x2013;1697. doi: 10.1097/j.pain.0000000000001950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001950</ArticleId><ArticleId IdType="pmc">PMC7302093</ArticleId><ArticleId IdType="pubmed">32701829</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S., Cohen M., Barke A., Korwisi B., Rief W., Treede R.D., IASP Taskforce for the Classification of Chronic Pain The IASP classification of chronic pain for ICD-11: Chronic secondary musculoskeletal pain. Pain. 2019;160:77&#x2013;82. doi: 10.1097/j.pain.0000000000001389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001389</ArticleId><ArticleId IdType="pubmed">30586074</ArticleId></ArticleIdList></Reference><Reference><Citation>Neblett R., Cohen H., Choi Y., Hartzell M.M., Williams M., Mayer T.G., Gatchel R.J. The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J. Pain. 2013;14:438&#x2013;445. doi: 10.1016/j.jpain.2012.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.11.012</ArticleId><ArticleId IdType="pmc">PMC3644381</ArticleId><ArticleId IdType="pubmed">23490634</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann-Lingen C., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale&#x2014;Deutsche Version (HADS-D) Verlag Hans Huber; Bern, Switzerland: 2011.</Citation></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Campayo J., Rodero B., Alda M., Sobradiel N., Montero J., Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med. Clin. 2008;131:487&#x2013;492. doi: 10.1157/13127277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13127277</ArticleId><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Scerbo T., Colasurdo J., Dunn S., Unger J., Nijs J., Cook C. Measurement properties of the central sensitization inventory: A systematic review. Pain Pract. 2018;18:544&#x2013;554. doi: 10.1111/papr.12636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12636</ArticleId><ArticleId IdType="pubmed">28851012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuesta-Vargas A.I., Neblett R., Chiarotto A., Kregel J., Nijs J., van Wilgen C.P., Pitance L., Knezevic A., Gatchel R.J., Mayer T.G., et al. Dimensionality and reliability of the Central Sensitization Inventory in a pooled multi-country sample. J. Pain. 2018;19:317&#x2013;329. doi: 10.1016/j.jpain.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2017.11.006</ArticleId><ArticleId IdType="pubmed">29198933</ArticleId></ArticleIdList></Reference><Reference><Citation>Olss&#xf8;n I., Mykletun A., Dahl A.A. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46. doi: 10.1186/1471-244X-5-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-5-46</ArticleId><ArticleId IdType="pmc">PMC1343544</ArticleId><ArticleId IdType="pubmed">16351733</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., de-la-Llave-Rinc&#xf3;n A.I., Fuensalida-Novo S., Florencio L.L., Ambite-Quesada S., Ortega-Santiago R., Arias-Bur&#xed;a J.L., Liew B.X.W., et al. Psychometric properties of the Hospital Anxiety and Depression Scale (HADS) in previously hospitalized COVID-19 patients. Int. J. Environ. Res. Public Health. 2022;19:9273. doi: 10.3390/ijerph19159273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19159273</ArticleId><ArticleId IdType="pmc">PMC9367824</ArticleId><ArticleId IdType="pubmed">35954630</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter J.S., Andrykowski M.A. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J. Psychosom. Res. 1998;45:5&#x2013;13. doi: 10.1016/S0022-3999(97)00298-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(97)00298-5</ArticleId><ArticleId IdType="pubmed">9720850</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Nijs J., Neblett R., Polli A., Moens M., Goudman L., Shekhar Patil M., Knaggs R.D., Pickering G., Arendt-Nielsen L. Phenotyping post-COVID pain as a nociceptive, neuropathic, or nociplastic pain condition. Biomedicines. 2022;10:2562. doi: 10.3390/biomedicines10102562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102562</ArticleId><ArticleId IdType="pmc">PMC9599440</ArticleId><ArticleId IdType="pubmed">36289827</ArticleId></ArticleIdList></Reference><Reference><Citation>Postigo-Martin P., Cantarero-Villanueva I., Lista-Paz A., Castro-Mart&#xed;n E., Arroyo-Morales M., Seco-Calvo J. A COVID-19 rehabilitation prospective surveillance model for use by physiotherapists. J. Clin. Med. 2021;10:1691. doi: 10.3390/jcm10081691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081691</ArticleId><ArticleId IdType="pmc">PMC8071011</ArticleId><ArticleId IdType="pubmed">33920035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R., Lyngdoh T., Kakkar A.K. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur. J. Clin. Investig. 2021;51:e13429. doi: 10.1111/eci.13429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E.A., Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Del Gaudio A., Vittori A., Bimonte S., Del Prete P., Forte C.A., Cuomo A., De Blasio E. COVID-Pain: Acute and late-onset painful clinical manifestations in COVID-19: Molecular mechanisms and research perspectives. J. Pain Res. 2021;14:2403&#x2013;2412. doi: 10.2147/JPR.S313978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S313978</ArticleId><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht D.S., Kim M., Akeju O., Torrado-Carvajal A., Edwards R.R., Zhang Y., Bergan C., Protsenko E., Kucyi A., Wasan A.D., et al. The neuroinflammatory component of negative affect in patients with chronic pain. Mol. Psychiatry. 2021;26:864&#x2013;874. doi: 10.1038/s41380-019-0433-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0433-1</ArticleId><ArticleId IdType="pmc">PMC7001732</ArticleId><ArticleId IdType="pubmed">31138890</ArticleId></ArticleIdList></Reference><Reference><Citation>De Couck M., Nijs J., Gidron Y. You may need a nerve to treat pain: The neurobiological rationale for vagal nerve activation in pain management. Clin. J. Pain. 2014;30:1099&#x2013;1105. doi: 10.1097/AJP.0000000000000071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0000000000000071</ArticleId><ArticleId IdType="pubmed">24451632</ArticleId></ArticleIdList></Reference><Reference><Citation>Macchi C., Bonalume V., Greco M.F., Mozzo M., Melfi V., Sirtori C.R., Magnaghi V., Corsini A., Ruscica M. Impact of Atorvastatin on skeletal muscle mitochondrial activity, locomotion and axonal excitability-evidence from ApoE-/- Mice. Int. J. Mol. Sci. 2022;23:5415. doi: 10.3390/ijms23105415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105415</ArticleId><ArticleId IdType="pmc">PMC9141374</ArticleId><ArticleId IdType="pubmed">35628225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., Huysmans E. Clinimetrics: The Central Sensitisation Inventory: A useful screening tool for clinicians, but not the gold standard. J. Physiother. 2022;68:207. doi: 10.1016/j.jphys.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2021.10.004</ArticleId><ArticleId IdType="pubmed">34895883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>